![Ross Barrow](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Ross Barrow served as the Chief Executive Officer & Director at Paranta Biosciences Ltd. and as a Non-Executive Director at Acrux Ltd.
Anciens postes connus de Ross Barrow
| Sociétés | Poste | Fin |
|---|---|---|
| ACRUX LIMITED | Directeur/Membre du Conseil | 27/02/2015 |
Paranta Biosciences Ltd.
 Paranta Biosciences Ltd. Pharmaceuticals: MajorHealth Technology Develops PB01 (recombinant human follistatin-288) for the treatment of fibrotic and inflammatory diseases | Directeur Général | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
11
Relations au 1er degré
2
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Acrux Ltd.
 Acrux Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products | Health Technology |
Paranta Biosciences Ltd.
Paranta Biosciences Ltd. Pharmaceuticals: MajorHealth Technology Develops PB01 (recombinant human follistatin-288) for the treatment of fibrotic and inflammatory diseases | Health Technology |
